The FDA typically follows the recommendations of its advisory panels but is not required to do so. If cleared for use, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind ...

Developed in partnership with agency Wieden+Kennedy Portland, Lilly’s Good Days officially launched on Sunday. The spot will air in the final slot before showings of Wicked: For Good and during the ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Eli Lilly and Indiana University (IU) have announced a new agreement, under which Lilly will provide up to $40m to IU in ...

Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single ...

Indiana University and Eli Lilly are working together to expand clinical trials in the state. IU President Pamela Whitten and ...

Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here ...

Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant amyloid clearance up to 3 years, in early symptomatic Alzheimer’s disease, ...

Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from ...

INDIANAPOLIS — Indiana University and pharmaceutical giant Eli Lilly have made official a five-year collaboration in which ...